Stevanato Group S P A (STVN) Growth Rates Comparisons to Medical Equipment & Supplies Industry, Sector, Market. Sales, Income, EPS
CSIMarket Company Name, Ticker, Suppliers, else..
 
Stevanato Group S p a   (NYSE: STVN)
 

Stevanato Group S P A Growth Comparisons

Select each growth Category to receive further Information




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

STVN Revenue Growth Rate Comparisons Company Industry Sector S&P 500
Y / Y Revenue Growth (Q4 MRQ) 7.45 % 7.07 % 8.07 % 9.17 %
Q / Q Revenue Growth (Q4 MRQ) - 1.17 % 1.81 % 4.22 %
Y / Y Revenue Growth (for 12 months ending Q4 TTM) 7.45 % 5.73 % 7.04 % %
Sequential Revenue Growth (for 12 months ending Q4 TTM) - 1.89 % 3.51 % 2.08 %
Revenue 5 Year Average Growth - 10.68 % 8.65 % 10.59 %


STVN's Growth Comparisons in IV. Quarter 2025




Stevanato Group S P A 's 7.45% year on year top-line increase in the fourth quarter 2025 to 1.33 billions, decelerating from Stevanato Group S P A 's growth trends, but compares favorably to the 7.07% growth in the Medical Equipment & Supplies industry, but Stevanato Group S P A 's growth compares unfavorably, to the 8.07% Revenue growth in the Healthcare sector.

Sequentially company's Revenue were unchanged from the third quarter results. . Looking into annual growth, sales grew by % on average in last five years, while S & P 500's including only Businesses with the fourth quarter 2025 earnings reports, average yearly sales growth is 10.59%.

STVN Growth Rates by Company's Segments

Segment Name
Y / Y
Sequential
Total Segments
-
-
Biopharmaceutical and Diagnostic Solutions
-
-
Biopharmaceutical and Diagnostic Solutions Customer
-
-
External Customers
-
-
Adjustments Eliminations and Unallocated Items
-
-
Adjustments Eliminations and Unallocated Items Inter-Segment
-
-
Biopharmaceutical and Diagnostic Solutions External Customers
-
-
Biopharmaceutical and Diagnostic Solutions Inter-Segment
-
-
Engineering
-
-
Engineering External Customers
-
-
Engineering Inter-Segment
-
-
Total External Customers
-
-
Total Inter-Segment
-
-
High-Value Solutions
-
-
Other Containment and Delivery Solutions
-
-
Revenue from Engineering
-
-
EMEA
-
-
APAC
-
-
North America
-
-
South America
-
-
Goods and Services Transferred at a Point in Time
-
-
Goods and Services Transferred Over Time
-
-
Biopharmaceutical and Diagnostic Solutions High-Value Solutions
-
-
Biopharmaceutical and Diagnostic Solutions Other Containment and Delivery Solutions
-
-
Biopharmaceutical and Diagnostic Solutions EMEA
-
-
Biopharmaceutical and Diagnostic Solutions APAC
-
-
Biopharmaceutical and Diagnostic Solutions North America
-
-
Biopharmaceutical and Diagnostic Solutions South America
-
-
Biopharmaceutical and Diagnostic Solutions Goods and Services Transferred at a Point in Time
-
-
Biopharmaceutical and Diagnostic Solutions Goods and Services Transferred Over Time
-
-
Engineering Revenue from Engineering
-
-
Engineering EMEA
-
-
Engineering APAC
-
-
Engineering North America
-
-
Engineering South America
-
-
Engineering Goods and Services Transferred at a Point in Time
-
-
Engineering Goods and Services Transferred Over Time
-
-
Italy
-
-
Total
-
-


Growth Rates of STVN's Income in the fourth quarter 2025


STVN Operating Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Operating Income Change (Q4 MRQ) 23.37 % -22.54 % 27.58 % 29.95 %
Sequential Operating Income Change (Q4 MRQ) - -56.34 % -17.34 % 4.5 %
Y / Y Operating Income Growth (Q4 TTM) 23.37 % 10.91 % 37.03 % 14.37 %
Sequential Operating Income Growth (Q4 TTM) 23.37 % -3.41 % 9.74 % 6.96 %
Operating Income 5 Year Avg. Change - 11.5 % 10.39 % 18.76 %


Income from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Income from Cont. Ops. Change (Q4 MRQ) 18.74 % 51938.12 % - 21.83 %
Sequential Income from Cont. Ops. Change (Q4 MRQ) - -18.73 % - 11.13 %
Y / Y Income from Cont. Ops. Change (Q4 TTM) 18.74 % 22.13 % -25.13 % 16.46 %
Sequential Income from Cont. Ops. Change (Q4 TTM) 18.74 % 24.91 % -6.43 % 6.05 %
Income from Cont. Ops. 5 Year Avg. Change - 5.35 % 0.17 % -28.52 %

STVN Net Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Net Income Growth (Q4 MRQ) 18.74 % - 16.75 % 21.56 %
Q / Q Net Income Growth (Q4 MRQ) - -34.95 % -34.6 % 11.12 %
Y / Y Net Income Change (Q4 TTM) 18.74 % 5.68 % 32.74 % 16.59 %
Sequential Net Income Change (Q4 TTM) 18.74 % 26.32 % 7.31 % 6.03 %
Net Income 5 Year Avg. Growth - 4.12 % 9.21 % 22.96 %

STVN's EPS Growth Rates


EPS from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS from Cont. Ops. Change (Q4 MRQ) - 49750.99 % - 21.83 %
Sequential EPS from Cont. Ops. Change (Q4 MRQ) - -17.51 % - 11.13 %
Y / Y EPS from Cont. Ops. Change (Q4 TTM) - - - -
Sequential EPS from Cont. Ops. Change (Q4 TTM) - - - -99.7 %
EPS from Cont. Ops. 5 Year Avg. Growth - -1.8 % 0.17 % -28.52 %



STVN EPS Net Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS Net Growth (Q4 MRQ) - - 16.75 % -28.52 %
Q / Q EPS Net Growth (Q4 MRQ) - -33.97 % -34.6 % 11.12 %
Y / Y EPS Net Change (for 12 months ending Q4 TTM) - - - -99.97 %
Sequential EPS Net Change (for 12 months ending Q4 TTM) - - - -99.87 %
EPS Net 5 Year Avg. Change - 4.12 % 9.21 % 22.96 %



Stevanato Group S P A reported bottom-line of $ 0.00 in the fourth quarter, compare to $ 0.00 in the same quarter a year ago. Medical Equipment & Supplies industry grew by 7.07%, while Healthcare sector increased by 16.75%, and overall market improved by 21.56%.

Sequentially company's EPS were unchanged from the third quarter results. . Looking into annual growth, income per share grew by % on average in the last five years, while the S & P 500's including only the businesses with the fourth quarter 2025 financial results, average yearly income per share growth is 22.96%.

STVN Cash Flow Growth Rates


Free Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Free Cash Flow Change (Q4 MRQ) - 9.68 % -10.43 % 2 %
Sequential Free Cash Flow Change (Q4 MRQ) - 11.07 % -28.82 % 22.32 %
Y / Y Free Cash Flow Change (Q4 TTM) - 11.94 % 11.09 % 11.81 %
Sequential Free Cash Flow Change (Q4 TTM) - 3.69 % 1.93 % 2.41 %
Free Cash Flow 5 Year Avg. Change - 3.81 % 0.92 % 8.28 %

Net Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Net Cash Flow Change (Q4 MRQ) - - -90.24 % 1035.72 %
Sequential Net Cash Flow Change (Q4 MRQ) - -90.75 % -99.01 % -
Y / Y Net Cash Flow Change (Q4 TTM) - 30.83 % -23.28 % -
Sequential Net Cash Flow Change (Q4 TTM) - 1641.65 % -25.11 % -
Net Cash Flow 5 Year Avg. Change - -9.69 % 6.46 % 1.06 %

Capital Expenditures Company Industry Sector S&P 500
Y / Y Capital Expenditures Change (Q4 MRQ) -12.84 % 4.78 % 9.45 % 23.41 %
Sequential Capital Expenditures Change (Q4 MRQ) - 10.56 % 18.78 % 18.97 %
Y / Y Capital Expenditures Change (Q4 TTM) -12.84 % -1.74 % 10.57 % 23.88 %
Sequential Capital Expenditures Change (Q4 TTM) -12.84 % 2.72 % 6.56 % 7.02 %
Capital Expenditures 5 Year Avg. Change - 8.3 % 9.18 % 14.72 %

Note
To view Detail Information & Trends click on Individual Category.
To see Industry, Sector or S&P 500 Performance, click on each Category respectivly, on the top of the Table.

For explanation of terms visit: Glossary
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Y/Y Annual




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.